The Latest Breaking News from 23andMe

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.”

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs

Herald and the Age opt not to use photograph of Thorpe wearing possum-skin cloak and shaking her fist at King Charles on page one. Plus: The Australian fails to read fine print

Some past employees weren’t exactly surprised when the entire board at 23andMe tester quit last month

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service, which involves ordering a saliva test, spitting into a tube, and sending it back to the company for a…

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

23andMe has recently come under fire. What does that mean for its 15 million customers?

Avid Ventures has raised $87 million for its second fund, Fortune can exclusively report.

The board has rejected both of Anne Wojcicki’s buyout proposals to save the struggling genetics company